Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Podda

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Genetics|March 29, 2019
ADA2 deficiency due to a novel structural variation in 22q11.1Alice Grossi, Roberto Cusano, Marta Rusmini, et al.
Vaccine|October 1, 1991
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDaA Podda, L Nencioni, I Marsili, et al.
The Journal of Pediatrics|July 1, 1993
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and childrenA Podda, E Carapella De Luca, L Titone, et al.
The Journal of Experimental Medicine|September 1, 1990
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129GA Podda, L Nencioni, M T De Magistris, et al.
The Journal of Pediatrics|May 1, 1992
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old childrenA Podda, E C De Luca, L Titone, et al.
Plant Physiology and Biochemistry : PPB|May 22, 2022
Modulation of class III peroxidase pathways and phenylpropanoids in Arundo donax under salt and phosphorus stressC Cocozza, P Bartolini, C Brunetti, et al.
The Journal of Pediatrics|June 1, 1994
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis VaccineA Podda, E C De Luca, B Contu, et al.
Journal of Plant Physiology|October 8, 2010
Comparative analysis of proteome changes induced by the two spotted spider mite Tetranychus urticae and methyl jasmonate in citrus leavesB E Maserti, R Del Carratore, C M Della Croce, et al.
Arthritis and Rheumatism|February 10, 2011
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trialFrancesco Zulian, Giorgia Martini, Cristina Vallongo, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adultsP Durando, D Fenoglio, A Boschini, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Genetics|March 29, 2019
ADA2 deficiency due to a novel structural variation in 22q11.1Alice Grossi, Roberto Cusano, Marta Rusmini, et al.
Vaccine|October 1, 1991
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDaA Podda, L Nencioni, I Marsili, et al.
The Journal of Pediatrics|July 1, 1993
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and childrenA Podda, E Carapella De Luca, L Titone, et al.
The Journal of Experimental Medicine|September 1, 1990
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129GA Podda, L Nencioni, M T De Magistris, et al.
The Journal of Pediatrics|May 1, 1992
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old childrenA Podda, E C De Luca, L Titone, et al.
Plant Physiology and Biochemistry : PPB|May 22, 2022
Modulation of class III peroxidase pathways and phenylpropanoids in Arundo donax under salt and phosphorus stressC Cocozza, P Bartolini, C Brunetti, et al.
The Journal of Pediatrics|June 1, 1994
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis VaccineA Podda, E C De Luca, B Contu, et al.
Journal of Plant Physiology|October 8, 2010
Comparative analysis of proteome changes induced by the two spotted spider mite Tetranychus urticae and methyl jasmonate in citrus leavesB E Maserti, R Del Carratore, C M Della Croce, et al.
Arthritis and Rheumatism|February 10, 2011
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trialFrancesco Zulian, Giorgia Martini, Cristina Vallongo, et al.
Clinical and Vaccine Immunology : CVI|November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adultsP Durando, D Fenoglio, A Boschini, et al.
Pageof 6